BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis
about
Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series)Pulmonary Arterial Hypertension and the Sex Hormone Paradox.Three novel BMPR2 mutations associated with advanced pulmonary arterial hypertensionThe cancer theory of pulmonary arterial hypertension.Treatment response in patients with idiopathic pulmonary arterial hypertension and a severely reduced diffusion capacity.Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension.Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development.Epidemiology and treatment of pulmonary arterial hypertension.Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial.A systematic review of genetic mutations in pulmonary arterial hypertension.Inducible pluripotent stem cells and pulmonary arterial hypertension: the future is now!Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing.Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension.The Efficacy of a Genetic Analysis of the BMPR2 Gene in a Patient with Severe Pulmonary Arterial Hypertension and an Atrial Septal Defect Treated with Bilateral Lung Transplantation.Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension.RV pressure overload: from hypertrophy to failure.DRUG INDUCED PULMONARY ARTERIAL HYPERTENSION: A PRIMER FOR CLINICIANS AND SCIENTISTS.Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.Improved Survival of Patients with Pulmonary Arterial Hypertension with BMPR2 Mutations in the Last Decade.[The cancer paradigm in pulmonary arterial hypertension: towards anti-remodeling therapies targeting metabolic dysfunction?]Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.Whole-exome sequencing improves genetic testing accuracy in pulmonary artery hypertension.[Towards new targets for the treatment of pulmonary arterial hypertension : Importance of cell-cell communications].Genetic analyses in a cohort of 191 pulmonary arterial hypertension patients.BMPR2 mutations and endothelial dysfunction in pulmonary arterial hypertension (2017 Grover Conference Series).Interventions and mechanisms of N-acetylcysteine on monocrotaline-induced pulmonary arterial hypertension.Clinical and genetic characteristics of pulmonary arterial hypertension in Lebanon.Circulating MicroRNA Markers for Pulmonary Hypertension in Supervised Exercise Intervention and Nightly Oxygen InterventionConsequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension
P2860
Q28078976-757D95DE-238B-4031-B117-47F9AEE62B74Q30241478-5616DBA4-8503-47B7-BF82-39E86A3795E1Q33580827-B92A3502-7CE1-4512-840D-9022EC534D70Q33788493-A568EA12-C383-4CEF-84FD-F0A007179CACQ38692036-AA925153-5761-4E13-A465-897300F40232Q38749645-3E4F8199-653D-480C-BA72-88314EEA28A9Q38779774-C009CABD-A341-410C-8753-E0A4F319F3F4Q39317865-F94C8D58-C263-47CE-AAA8-A6AF57F110FBQ39359218-5F5C7755-985C-45DC-816F-99DAC27A5431Q40591652-B3963C2A-C633-4294-BE3A-992411595EE8Q41228335-A795B61C-DA4F-4332-8A26-D4770430344EQ42332327-9AA9623C-17D9-44BA-B158-56BFF25D1E78Q47108856-DB6015E3-FD5C-4889-B91A-AA32485F16C7Q47253821-0BD18994-86D6-4B3C-A9A5-5919AA4D60AAQ47665372-643169BF-D1AF-4DDC-AC5B-F101A94EF868Q48313046-FA3F4EE6-8415-4F0B-9602-A129B05CBFD7Q49679389-0FA2D169-F1F5-48C1-977E-65CE6C31F8EEQ50124360-261B9328-8C23-4B32-A150-4CBE2A9B6507Q50942066-1D661950-A738-4B06-B83E-52AAF64C9390Q51726526-D6CE088E-603C-4C4D-9A4C-2B6D7289958DQ52312423-7EBBF99B-C02A-4D6C-BFFF-E212842F8395Q52590989-62AAE22D-6946-4F9B-81A2-C1C0BE352E44Q52685722-A02CBB3F-FBCD-4BDE-BDE7-02EBC2389E33Q53767909-698DDBE8-EA37-4017-87DB-7320AD9B88F0Q54940554-79F37AAF-FF25-4BC5-8B4B-FF40CBC5D13BQ55008475-593301C9-D53C-4322-BE6F-743BAB5A305EQ55172434-3C208FB4-A781-41A8-BEAE-8E1B0654DE9CQ55286562-7B1AAFEC-AA52-4C21-98B4-691A755FA90EQ57092198-C7280567-DE16-4071-ADED-46212D278D8FQ58703705-2E308C00-BA2D-4A16-A365-BCD60C56B139
P2860
BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
BMPR2 mutations and survival i ...... participant data meta-analysis
@ast
BMPR2 mutations and survival i ...... participant data meta-analysis
@en
type
label
BMPR2 mutations and survival i ...... participant data meta-analysis
@ast
BMPR2 mutations and survival i ...... participant data meta-analysis
@en
prefLabel
BMPR2 mutations and survival i ...... participant data meta-analysis
@ast
BMPR2 mutations and survival i ...... participant data meta-analysis
@en
P2093
P2860
P50
P1476
BMPR2 mutations and survival i ...... participant data meta-analysis
@en
P2093
Alessandra Manes
Barbara Girerd
Christina Eichstaedt
Ekkehard Grünig
Emanuele Di Angelantonio
Eric D Austin
Florent Soubrier
Greg Elliott
Gérald Simonneau
Ikue Nakayama
P2860
P304
P356
10.1016/S2213-2600(15)00544-5
P50
P577
2016-01-18T00:00:00Z